BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang Z, Zeng X, Wu Y, Liu Y, Zhang X, Song Z. Cuproptosis-Related Risk Score Predicts Prognosis and Characterizes the Tumor Microenvironment in Hepatocellular Carcinoma. Front Immunol 2022;13:925618. [DOI: 10.3389/fimmu.2022.925618] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 19.0] [Reference Citation Analysis]
Number Citing Articles
1 Nie H, Wang H, Zhang M, Ning Y, Chen X, Zhang Z, Hu X, Zhao Q, Chen P, Fang J, Wang F. Comprehensive analysis of cuproptosis-related genes in prognosis, tumor microenvironment infiltration, and immunotherapy response in gastric cancer. J Cancer Res Clin Oncol 2022. [DOI: 10.1007/s00432-022-04474-4] [Reference Citation Analysis]
2 Chen J, Guan Y, Li C, Du H, Liang C. Identification and validation of a novel cuproptosis-related lncRNA gene signature to predict prognosis and immune response in bladder cancer. Discov Oncol 2022;13:133. [PMID: 36454396 DOI: 10.1007/s12672-022-00596-w] [Reference Citation Analysis]
3 Wang Q, Xu Y. Comprehensive analysis of cuproptosis-related lncRNAs model in tumor immune microenvironment and prognostic value of cervical cancer. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1065701] [Reference Citation Analysis]
4 Luo L, Li A, Fu S, Du W, He L, Zhang X, Wang Y, Zhou Y, Yunpeng Y, Li Z, Hong S. [Cuproptosis-related immune gene signature predicts clinical benefits from anti-PD-1/PD-L1 therapy in non-small-cell lung cancer. Immunol Res 2022. [DOI: 10.1007/s12026-022-09335-3] [Reference Citation Analysis]
5 Wang J, Qin D, Tao Z, Wang B, Xie Y, Wang Y, Li B, Cao J, Qiao X, Zhong S, Hu X. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1056932] [Reference Citation Analysis]
6 Zhang L, Xu J, Chu X, Zhang H, Yao X, Zhang J, Guo Y. Identification of the cuproptosis-related molecular subtypes and an immunotherapy prognostic model in hepatocellular carcinoma. BMC Bioinformatics 2022;23:485. [DOI: 10.1186/s12859-022-04997-0] [Reference Citation Analysis]
7 Wang L, Yao B, Yang J, Tian Z, He J. Construction of a novel cuproptosis-related gene signature for predicting prognosis and estimating tumor immune microenvironment status in papillary thyroid carcinoma. BMC Cancer 2022;22:1131. [DOI: 10.1186/s12885-022-10175-5] [Reference Citation Analysis]
8 Zhang Z, Wang B, Xu X, Xin T. Cuproptosis-related gene signature stratifies lower-grade glioma patients and predicts immune characteristics. Front Genet 2022;13. [DOI: 10.3389/fgene.2022.1036460] [Reference Citation Analysis]
9 Xu D, Yang F, Chen Y, Zhu H, Sun H, Shen T, Zhu Y, Zhou G, Chen D, Yang X, Lin K, Xia C. A novel cuproptosis-related gene signature for the prediction of liver cancer prognosis identified DLAT is a potential therapeutic target.. [DOI: 10.1101/2022.10.23.22280648] [Reference Citation Analysis]
10 Song X, Hou L, Zhao Y, Guan Q, Li Z. Metal-dependent programmed cell death-related lncRNA prognostic signatures and natural drug sensitivity prediction for gastric cancer. Front Pharmacol 2022;13:1039499. [DOI: 10.3389/fphar.2022.1039499] [Reference Citation Analysis]
11 Liu J, Liu L, Li Z, Luo Y, Liang F. The role of cuproptosis-related gene in the classification and prognosis of melanoma. Front Immunol 2022;13:986214. [DOI: 10.3389/fimmu.2022.986214] [Reference Citation Analysis]
12 He Y, Zhang S, Zhang X, Zhang Y, Xie B, Zhang J, Long W, Liu Q. A prognostic cuproptosis gene signature predicts immune function and chemotherapy response in gliomas.. [DOI: 10.21203/rs.3.rs-2155356/v1] [Reference Citation Analysis]
13 Zhao X, Chen J, Yin S, Shi J, Zheng M, He C, Meng H, Han Y, Han J, Guo J, Yuan Z, Wang Y. The expression of cuproptosis-related genes in hepatocellular carcinoma and their relationships with prognosis. Front Oncol 2022;12:992468. [DOI: 10.3389/fonc.2022.992468] [Reference Citation Analysis]
14 Li M, Song Q, Bai Y, Hua F, Wu T, Liu J. Comprehensive analysis of cuproptosis in immune response and prognosis of osteosarcoma. Front Pharmacol 2022;13:992431. [DOI: 10.3389/fphar.2022.992431] [Reference Citation Analysis]
15 Zhao C, Zhang Z, Tao J. A Novel Ferroptosis-Related Signature for Prediction of Prognosis, Immune Profiles and Drug Sensitivity in Hepatocellular Carcinoma Patients. Current Oncology 2022;29:6992-7011. [DOI: 10.3390/curroncol29100550] [Reference Citation Analysis]
16 Zhao C, Zhang Z, Jing T. A novel signature of combing cuproptosis- with ferroptosis-related genes for prediction of prognosis, immunologic therapy responses and drug sensitivity in hepatocellular carcinoma. Front Oncol 2022;12:1000993. [DOI: 10.3389/fonc.2022.1000993] [Reference Citation Analysis]
17 Wang T, Liu Y, Li Q, Luo Y, Liu D, Li B. Cuproptosis-related gene FDX1 expression correlates with the prognosis and tumor immune microenvironment in clear cell renal cell carcinoma. Front Immunol 2022;13:999823. [DOI: 10.3389/fimmu.2022.999823] [Reference Citation Analysis]
18 Li X, Dai Z, Liu J, Sun Z, Li N, Jiao G, Cao H. Characterization of the functional effects of ferredoxin 1 as a cuproptosis biomarker in cancer. Front Genet 2022;13:969856. [DOI: 10.3389/fgene.2022.969856] [Reference Citation Analysis]
19 Ding L, Li W, Tu J, Cao Z, Li J, Cao H, Liang J, Liang Y, Yu Q, Li G. Identification of cuproptosis-related subtypes, cuproptosis-related gene prognostic index in hepatocellular carcinoma. Front Immunol 2022;13:989156. [DOI: 10.3389/fimmu.2022.989156] [Reference Citation Analysis]
20 Nie H, Wang H, Zhang M, Ning Y, Chen X, Zhang Z, Hu X, Zhao Q, Chen P, Fang J, Wang F. Comprehensive Analysis of Cuproptosis-related genes in prognosis, tumor microenvironment infiltration, and Immunotherapy response in gastric cancer.. [DOI: 10.21203/rs.3.rs-2018538/v1] [Reference Citation Analysis]
21 Ding Q, Chen X, Hong W, Wang L, Liu W, Cai S, Chen X, Lu J, Qiu S, Yang J. The Prognostic Role of Cuproptosis in Head and Neck Squamous Cell Carcinoma Patients: A Comprehensive Analysis. Disease Markers 2022;2022:1-32. [DOI: 10.1155/2022/9996946] [Reference Citation Analysis]
22 Li Z, Zhang H, Wang X, Wang Q, Xue J, Shi Y, Wang M, Wang G, Zhang J. Identification of cuproptosis-related subtypes, characterization of tumor microenvironment infiltration, and development of a prognosis model in breast cancer. Front Immunol 2022;13:996836. [DOI: 10.3389/fimmu.2022.996836] [Cited by in F6Publishing: 1] [Reference Citation Analysis]